Corin Group PLC (LSE: CRG, “Corin” or “the Group”), a leading manufacturer and supplier of orthopaedic devices, has announced the renewal of its agreement to distribute the LARS ligament augmentation system for a further two years through to 31 December 2013. The announcement was made on 9th August 2011.
Under the terms of the agreement, Corin will have the exclusive rights to distribute LARS ligaments in a number of countries including the UK and Australia, as well as non-exclusive rights in a number of other countries.
Peter Huntley, Corin’s Chief Executive, said; “We are delighted to have agreed the continuation of our distribution relationship with LARS and look forward to investing further behind the LARS product in the coming years”
Source: Corin press release
published: September 16, 2011 in: Contracts, Financial, Orthopaedics, Shoulder